mitomycin has been researched along with carboplatin in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.90) | 18.7374 |
1990's | 37 (33.33) | 18.2507 |
2000's | 49 (44.14) | 29.6817 |
2010's | 21 (18.92) | 24.3611 |
2020's | 3 (2.70) | 2.80 |
Authors | Studies |
---|---|
Athanassiades, H; Athanassiades, P; Giannioti, E; Kokolakis, N; Psychogiou, E | 1 |
Fujii, S | 1 |
Shimada, Y; Yokoyama, T | 1 |
Hayashihara, K; Hino, M; Kobayashi, K; Nakahiro, K; Niitani, H; Takemoto, T; Wasai, S | 1 |
Covens, A; Mazurka, J; O'Connell, G; Rusthoven, J | 1 |
Gotoda, A; Kamiyama, T; Matsuoka, S; Nagabuchi, E; Nakajima, Y; Saito, M; Uchino, J; Une, Y | 1 |
Vogelzang, NJ | 1 |
Kajikawa, F; Kashimoto, S; Nakamura, S; Nakata, K | 1 |
Hirano, T; Ifuku, M; Ishikawa, H; Kajiwara, K; Kawaguchi, A; Kusano, H; Nakagoe, T; Nakamura, Y; Shimizu, T; Shiraishi, E | 1 |
Bonomi, PD; Cassileth, BR; Ezdinli, EZ; Finkelstein, DM; Ruckdeschel, JC; Wolter, JM | 1 |
Kamby, C; Nielsen, OS; Sengeløv, L; von der Maase, H | 1 |
Cheng, LF; Li, L; Wang, HZ | 1 |
Addamo, GF; Ardizzoni, A; Baldini, E; Borghini, U; Bruzzi, P; Conte, PF; De Marinis, F; Lionetto, R; Pennucci, MC; Portalone, L | 1 |
Kudo, C; Saito, M; Yoshida, T | 1 |
Kosmidis, P; Kyparidou, E; Lygidakis, NJ; Parissis, J; Ziras, N | 1 |
Bizjak, L; Jernej, B; Kapitanović, S; Osmak, M | 1 |
Gohma, I; Inoue, T; Kobashi, Y; Kohri, Y; Matsumura, Y; Mino, M; Oida, K; Taguchi, Y; Takano, Y; Tomii, K | 1 |
Backes, MG; Blanock, K; Emerson, EO; Jani, JP; Rihn, C; Scalamogna, D; Singh, SV; Specht, S; Stemmler, N; Xu, BH | 1 |
Endo, Y; Kunimi, K; Lee, SW; Noguchi, M; Ohkawa, M; Sasaki, T; Uchibayashi, T | 1 |
Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ | 1 |
Fujimura, T; Fushida, S; Hirono, Y; Kawamura, T; Kinami, S; Minami, M; Miwa, K; Miyazaki, I; Nishimura, G; Noguchi, M; Nojima, N; Sato, T; Shiobara, S; Yonemura, Y | 1 |
DePoli, F; Favaretto, A; Festi, G; Fiorentino, MV; Lauro, S; Morabito, A; Oniga, F; Ossana, L; Paccagnella, A; Sartore, F | 1 |
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
Brandt, A; Palmer, AJ | 1 |
Hoskins, PJ; Lee, N; McMurtrie, EM; Pike, JA; Swenerton, KD | 1 |
Yamazaki, N | 1 |
Cachat, F; Guignard, JP | 1 |
Ando, S; Katanuma, A; Maekubo, H; Mori, M; Tsuji, K | 1 |
Barriere, JR; Bonnaud, F; Clavier, J; Kleisbauer, JP; Paillotin, D; Pignon, T; Poirier, R; Pommier De Santi, P; Robinet, G; Taytard, A; Thomas, P; Vernenegre, A | 1 |
Amaike, H; Kan, K; Kawachi, H; Mizuta, N; Naitoh, K; Ohmori, K; Ohmori, Y; Tsuruta, A; Yanada, M | 1 |
Antilli, A; Ardizzoni, A; Baldini, E; Bandera, M; Barbera, S; Borghini, U; Cacciani, GC; Crippa, M; De Marinis, F; Ferrara, G; Fioretti, M; Galeasso, G; Lanfranco, C; Lepidini, G; Migliorino, MR; Noseda, MA; Pennucci, MC; Portalone, L; Raimondi, M; Rinaldi, M; Romano, F; Rosso, R; Salvati, F; Sunseri, G; Tibaldi, C | 1 |
Hirota, S; Hishikawa, Y; Honda, K; Kono, K; Obayasi, K; Soejima, T; Takada, Y; Watanabe, H | 1 |
Benbow, U; Brinckerhoff, CE; Hamilton, JW; Maitra, R | 1 |
Balestreri, L; Morassut, S | 1 |
Kurano, R; Ono, K; Semba, H; Seto, M; Seto, T | 1 |
Anthony, SP; Davis, SA; Hamilton, JW; Ihnat, MA; Kaltreider, RC; Lariviere, JP; Nervi, AM; Pesce, CA; Warren, AJ | 1 |
Hu, G; Liang, W; Zhu, K | 1 |
Sandler, A | 1 |
Alexopoulos, CG; Baumöhl, J; Berghmans, T; Florin, MC; Klastersky, J; Koumakis, G; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Schmerber, J; Sculier, JP; Thiriaux, J; Zacharias, C | 1 |
Arizumi, T; Chida, H; Itakura, K; Mouri, T; Suzuki, J | 1 |
Fukuda, J; Haneji, T; Ikemura, K; Kobayashi, N; Muraki, Y; Oya, R; Seta, C; Tateishi, A | 1 |
Inoue, K; Kanamaru, T; Kawaguchi, K; Nishio, Y; Tanaka, K; Ueno, N; Yamamoto, M | 1 |
Kanemichi, Y; Ohmae, S; Ohta, T; Tokishita , S; Yamagata, H; Yamaya, K | 1 |
Berger, R; Brenner, H; Ghodsizade, E; Katz, A; Rath, P; Tichler, T | 1 |
Bafaloukos, D; Brountzos, EN; Kelekis, DA; Magoulas, D; Panagiotou, IE | 1 |
Rixe, O | 1 |
Babović, N; Elezar, E; Gavrilović, D; Jelić, S; Kovacević, S; Kovcin, V; Mitrović, L; Radosavljević, D; Radulović, S; Tomasević, Z | 1 |
Ashley, S; Gregory, RK; Norton, A; O'Brien, ME; Smith, IE | 1 |
Mornex, F | 1 |
Cai, L; Liao, Q; Wu, Y; Zhao, Y; Zhu, Y | 1 |
Liu, J; Tang, WJ; Yu, RC | 1 |
Tao, K; Zhou, X | 1 |
Adem, C; Chiras, J; Guillevin, R; Lo, D; Reb, P; Vallée, JN | 1 |
Allen, M; Andreyev, J; Cunningham, D; Hill, M; Kelleher, M; Norman, A; Tebbutt, NC | 1 |
Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N | 1 |
Brega-Massone, PP; Cataldo, I; Conti, B; Ferro, F; Lequaglie, C | 1 |
Hoshino, H; Saitoh, K; Seki, H; Sodemoto, T; Takada, T; Uekusa, T | 1 |
Artioli, F; Barbieri, F; Biason, R; Cacciani, GC; Ceresoli, G; Cetto, GL; Chiarion Sileni, V; De Pangher, V; Favaretto, A; Ghi, MG; Giusto, M; Morabito, A; Mosconi, P; Oniga, F; Paccagnella, A; Parodi, G; Santo, A; Soresi, F; Torri, W; Verusio, C; Villa, E | 1 |
Antos, F; Gilbert, Z; Serclova, Z; Skala, M; Vitek, P | 1 |
Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Richez, M; Sculier, JP; Thiriaux, J; VanHoutte, P; Wackenier, P | 1 |
Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX | 1 |
Cai, SM; Huang, X; Li, ZT; Tang, J; Zang, RY | 1 |
Terauchi, F | 1 |
Aoki, Y; Fujita, K; Kurata, H; Tanaka, K; Watanabe, M | 1 |
Eisen, TG; Gower, NH; Gregory, WM; Harper, PG; Hatton, M; James, LE; Johnson, PW; Lee, SM; Littler, JA; Martin, WM; Qian, W; Rankin, EM; Rudd, RM; Spiro, SG | 1 |
Cai, L; Cui, NJ; Gu, MF; Li, GH; Li, JQ; Li, Q; Liu, H; Liu, MZ; Wang, XS; Zhang, YQ | 1 |
Dietz, A; Dollner, R; Hildebrandt, G; Weber, A | 1 |
Ichinose, Y; Okamoto, T | 1 |
Ott, OJ; Sauer, R; Strnad, V; Windschall, A | 1 |
Berghmans, T; Sculier, JP | 1 |
Govindan, R | 1 |
Belka, C; Budach, V; Budach, W; Dietz, K; Hehr, T | 1 |
Anderson, H; Ashcroft, L; Baka, S; Booton, R; Dark, G; Dunlop, D; Laurence, V; Lorigan, P; Nicolson, M; O'Brien, M; O'Byrne, K; Snee, M; Thatcher, N | 1 |
Depierre, A | 1 |
Bryan, B; Dezube, BJ; Konstantinopoulos, PA; Pantanowitz, L; Schlecht, HP | 1 |
Kang, YH; Kim, JH; Kim, SH; Lee, KA; Paik, SG; Park, SN; Yang, Y; Yoon, DY | 1 |
Jia, HS; Sun, T; Zhang, JR | 1 |
Okamoto, H; Watanabe, K | 1 |
Ashcroft, L; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T | 1 |
Cho, YH; Hah, JH; Heo, DS; Kim, DW; Kim, KH; Lee, SH; Rhee, CS; Sung, MW; Wu, HG | 1 |
Czyzewicz, G; Jasiówka, M; Kojs-Pasińska, E; Rolski, J; Zemełka, T | 1 |
Ashworth, A; Boyd, J; Brough, R; Edwards, SL; Levine, DA; Lord, CJ; Natrajan, R; Reis-Filho, JS; Vatcheva, R | 1 |
Arnedos, M; Ashley, S; Johnston, S; Nerurkar, A; Popat, S; Sirohi, B; Smith, IE; Walsh, G | 1 |
Anderson, S; Ashton, A; Jenkins, P; Wronski, S | 1 |
Eng, C; Pathak, P | 1 |
Deutsch, E; Loriot, Y; Mordant, P; Olaussen, KA; Soria, JC | 1 |
Braccioni, F; Breda, C; Favaretto, A; Loreggian, L; Magro, C; Marulli, G; Pasello, G; Rea, F; Sotti, G; Stragliotto, S | 1 |
Chen, CH; Chiang, PH; Kang, CH | 1 |
Chiba, Y; Fukuoka, M; Hida, T; Imamura, F; Iwamoto, Y; Katakami, N; Kawahara, M; Kudo, S; Nakagawa, K; Nishimura, Y; Saka, H; Satouchi, M; Sawa, T; Semba, H; Seto, T; Takeda, K; Tsujino, K; Uejima, H; Yamamoto, N; Yokota, S | 1 |
Lentz, S; Levine, EA; Parson, EN; Russell, G; Shen, P; Stewart, JH | 1 |
Jafari, M; Kislukhin, G; Long, AD; Murphy, ML | 1 |
Gao, M; Huang, A; Liu, J; Wang, B; Zhuo, L | 1 |
Levine, EA; Randle, RW; Shen, P; Stewart, JH; Swett, KR; Swords, DS; Votanopoulos, KI | 1 |
Gushchin, V; Jimenez, WA; Macdonald, R; Nieroda, C; Sardi, A; Sittig, M | 1 |
Ozdemir, O; Ozdemir, P; Ozhan, MH; Uluer, H; Veral, A | 1 |
Chen, H; Chen, SP; Gao, MQ; Huang, AM; Wu, MX; Zhuo, LJ | 1 |
Namikawa, K; Oashi, K; Omata, W; Tanaka, R; Tsutsumida, A; Yamamoto, Y; Yamazaki, N | 1 |
Levine, EA; Loggie, BL; Russell, GB; Shen, P; Stewart, JH; Votanopoulos, KI | 1 |
Carvalho, MA; Carvalho, RS; Chammas, R; Fernandes, VC; Monteiro, AN; Nepomuceno, TC; Rodrigues, DC; Suarez-Kurtz, G; Woods, NT | 1 |
Bathla, L; Govindarajan, V; Loggie, BW; Shetty, SJ; Thomas, P | 1 |
Chen, CH; Chiang, PH; Shen, YC | 1 |
King, EG; Kislukhin, G; Long, AD; Walters, KN | 1 |
Huang, J; Li, B; Li, Q; Shen, J; Wang, J; Yuan, Y; Zheng, Y; Zou, R | 1 |
Ali-El-Dein, B; Babjuk, M; Burger, M; Chang, SS; Clayman, RH; Daneshmand, S; Efstathiou, JA; Fritsche, HM; Gakis, G; Galland, S; Hrbacek, J; Keegan, KA; Mischinger, J; Morgan, TM; Olugbade, K; Rink, M; Schubert, T; Stenzl, A; Thalmann, GN; Todenhöfer, T; Zaid, HB | 1 |
Fujiwara, Y; Goto, Y; Horinouchi, H; Kanda, S; Nokihara, H; Ohe, Y; Sumi, M; Tamura, T; Yamamoto, N | 1 |
Albrecht, T; Michalik, K; Nolte-Ernsting, C; Pereira, PL; Pützler, M; Schicho, A; Stroszczynski, C; Wiggermann, P | 1 |
Granov, DA; Korovina, YV; Moiseenko, AV; Polikarpov, AA; Rozengauz, EV; Shelkoplyas, EN; Tarazov, PG | 1 |
Namikawa, K; Takahashi, A; Tsutsui, K; Yamazaki, N | 1 |
Ángeles-Bueno, WG; Díaz-Sifuentes, JM; Mendoza-Medina, DF; Mendoza-Sánchez, F; Montes-López, GA; Pérez-Landeros, JE | 1 |
Andrews, NP; Chen, CZ; Chen, HW; Duan, Z; Fan, M; Li, JJ; Shen, J; Wang, J | 1 |
Arjona-Sanchez, A; Aziz, O; Briceño, J; Casado-Adam, A; Esquivel, J; Glehen, O; Nedelcut, DS; Passot, G; Piso, P; Rodriguez-Ortiz, L; Rufian-Peña, S; Salti, G; Sanchez-Hidalgo, JM; Selvasekar, CR; Sommariva, A; Turaga, K; Van der Speeten, K; Yonemura, Y | 1 |
14 review(s) available for mitomycin and carboplatin
Article | Year |
---|---|
[Chemotherapy for advanced pancreatic carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Fluorouracil; Humans; Mitomycin; Mitomycins; Pancreatic Neoplasms; Streptozocin | 1992 |
Nephrotoxicity from chemotherapy: prevention and management.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Gallium; Humans; Ifosfamide; Kidney Diseases; Methotrexate; Mitomycin; Neoplasms; Nitrosourea Compounds; Plicamycin | 1991 |
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Etoposide; Gemcitabine; Health Care Costs; Humans; Ifosfamide; Insurance, Health, Reimbursement; Italy; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases; Vinblastine; Vinorelbine | 1996 |
[Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Skin Neoplasms; Sweat Gland Neoplasms; Vincristine | 1997 |
[The kidney in children under chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Ifosfamide; Kidney; Kidney Diseases; Kidney Function Tests; Methotrexate; Mitomycin; Semustine | 1996 |
[Hepatic chemoembolization in a patient allergic to iodinated contrast media: the use of Gd-DTPA].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoembolization, Therapeutic; Contrast Media; Drug Hypersensitivity; Epirubicin; Female; Gadolinium DTPA; Humans; Iodized Oil; Liver; Liver Neoplasms; Magnetic Resonance Angiography; Mitomycin | 1999 |
Chemotherapy in metastatic non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Mitomycin; Paclitaxel; Taxoids; Tirapazamine; Triazines; Vinblastine; Vinorelbine | 2000 |
[Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Irinotecan; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Topoisomerase I Inhibitors; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
[Decision making in non resectable head and neck tumours].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Decision Making; Fluorouracil; Forecasting; Head; Head and Neck Neoplasms; Humans; Meta-Analysis as Topic; Mitomycin; Mouth; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Randomized Controlled Trials as Topic | 2005 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Pneumonectomy; Postoperative Care; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vinblastine; Vindesine; Vinorelbine | 2005 |
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Mitomycin; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2006 |
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Drug Therapy; Etoposide; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mutation; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome | 2009 |
Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Epirubicin; Ethiodized Oil; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 2014 |
Use of synthetic stomata in abdominal carcinomatosis. Case report and literature review.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; Argon Plasma Coagulation; Bevacizumab; Carboplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Doxorubicin; Drainage; Fatal Outcome; Female; Humans; Hyperthermia, Induced; Intestinal Neoplasms; Intestinal Perforation; Mitomycin; Ovarian Neoplasms; Polyethylene Glycols; Surgical Stomas | 2019 |
26 trial(s) available for mitomycin and carboplatin
Article | Year |
---|---|
Carboplatin, vinblastine and mitomycin-C in the treatment of non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vinblastine | 1992 |
Systemic mitomycin C as second-line treatment for metastatic urothelial cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Neoplasm Metastasis; Urinary Bladder Neoplasms | 1995 |
[Primary hepatic carcinoma treated by chemoembolization--a clinical analysis of 20 cases with survival period longer than 3 years].
Topics: Adult; Aged; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care; Survival Rate | 1994 |
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Interferons; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins | 1995 |
Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Interferon-gamma; Interleukin-2; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Mitomycin; Necrosis; Pilot Projects; Spleen; Survival Rate; Tomography, Emission-Computed | 1995 |
Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Analysis; Treatment Outcome; Vinblastine | 1996 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Radiation-Sensitizing Agents; Vinblastine; Vindesine; Vinorelbine | 1997 |
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vinblastine; Vindesine | 1998 |
[Percutaneous transfemoral arterial implantation of drug delivery system for arterial infusion therapy of advanced primary hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Prospective Studies; Survival Rate | 1998 |
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Survival Analysis; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome | 2000 |
[Dose-intensive chemotherapy with continuous infusion 5-fluorouracil].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Neoplasms; Time Factors | 1999 |
Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; Vindesine | 2001 |
[Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphocyte Count; Male; Mitomycin; Moxibustion; Phytotherapy; Stomach Neoplasms; T-Lymphocyte Subsets | 2002 |
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Neutropenia; Pain; Palliative Care; Pancreatic Neoplasms; Stomach Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome; Weight Loss | 2003 |
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Quality of Life; Survival Rate; Time Factors; Vinblastine | 2003 |
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Female; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Proportional Hazards Models; Quality of Life; Survival Analysis; Treatment Outcome; Vinblastine | 2004 |
[Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Postoperative Period; Survival Rate; Thymalfasin; Thymosin | 2004 |
Combination chemotherapy with irinotecan hydrochloride (CPT-11) and mitomycin C in platinum-refractory ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Middle Aged; Mitomycin; Ovarian Neoplasms; Pilot Projects | 2004 |
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Survival Rate; Treatment Outcome | 2005 |
[External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Epirubicin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Particle Accelerators; Survival Rate; Treatment Outcome | 2005 |
Chemotherapy for metastatic NSCLC: current status and future direction.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Survival Analysis; Treatment Outcome | 2005 |
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Quality of Life; Survival Analysis; Taxoids; Vinblastine | 2006 |
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; DNA Repair; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Neoplasms, Squamous Cell; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Treatment Outcome | 2007 |
A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Radiation Injuries; Radiotherapy, Conformal; Survival Rate; Vinblastine | 2009 |
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Radiotherapy, Adjuvant; Vindesine | 2010 |
71 other study(ies) available for mitomycin and carboplatin
Article | Year |
---|---|
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubicin; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1992 |
[Estimating doses of anti-cancer agents in sensitivity tests in vitro].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Mitomycin; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay | 1992 |
Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Resistance; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1992 |
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins | 1991 |
Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Interleukin-1; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Neoplasms, Experimental; Recombinant Proteins; Survival Analysis; Thiotepa | 1991 |
[A study on hepatic arterial infusion for metastatic liver tumor].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Doxorubicin; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Stomach Neoplasms; Survival Rate | 1991 |
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Organoplatinum Compounds; Patient Participation; Procarbazine; Progesterone; Quality of Life; Vinblastine | 1988 |
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytotoxicity, Immunologic; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Macrophages; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Proteins; Picibanil; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Glutathione; Glutathione Transferase; Humans; Laryngeal Neoplasms; Mitomycin; Proto-Oncogenes; Tumor Cells, Cultured; Vinblastine; Vincristine | 1995 |
[A case of lung cancer with choroidal metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Choroid Neoplasms; Cisplatin; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mitomycin; Vindesine | 1995 |
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Buthionine Sulfoximine; Cadmium; Cadmium Chloride; Carboplatin; Cell Line; Cell Survival; Chlorides; Cisplatin; Drug Resistance; Gene Expression; Glutathione; Glutathione Transferase; Humans; Isoenzymes; Kinetics; Metallothionein; Methionine Sulfoximine; Mitomycin; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Studies of effects of anticancer agents in combination with/without hyperthermia on metastasized human bladder cancer cells in chick embryos using the polymerase chain reaction technique.
Topics: Animals; Antineoplastic Agents; Base Sequence; Carboplatin; Cell Division; Cell Transplantation; Chick Embryo; Cisplatin; DNA Primers; DNA, Neoplasm; Doxorubicin; Gene Expression Regulation, Neoplastic; Globins; Humans; Hyperthermia, Induced; Liver; Liver Neoplasms; Mitomycin; Molecular Sequence Data; Polymerase Chain Reaction; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Ifosfamide; Leukemia P388; Mammary Neoplasms, Animal; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Sarcoma, Experimental; Vinblastine | 1994 |
[Chemohyperthermic peritoneal perfusion and high-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced colon cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hyperthermia, Induced; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitomycin; Perfusion; Peritoneum | 1996 |
"MECCA": a developmental, dose-intensive, non-cross-resistant platinum-based chemotherapy for advanced ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms | 1996 |
[Successful 5'-DFUR, CDDP and MMC combination therapy and 5'-DFUR and carboplatin combination therapy for a patient with inoperable advanced gastric cancer with peritonitis carcinomatosa].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Floxuridine; Humans; Male; Mitomycin; Peritonitis; Stomach Neoplasms; Survivors | 1997 |
[A CR case of amylase-producing tumor treated by hyperthermochemotherapy].
Topics: Adenocarcinoma; Amylases; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Floxuridine; Humans; Hyperthermia, Induced; Middle Aged; Mitomycin; Neoplasms, Unknown Primary; Peritoneal Neoplasms | 1998 |
[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophagitis; Esophagoscopy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Radiation Injuries; Radiotherapy; Vindesine | 1998 |
Selective inhibition of collagenase-1, gelatinase A, and gelatinase B by chemotherapeutic agents.
Topics: Acetylcysteine; Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Gelatinases; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Melanoma; Metalloendopeptidases; Mitomycin; Neoplasm Invasiveness; Protease Inhibitors; Tumor Cells, Cultured | 1999 |
[A long-term survivor of extensive-stage small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survivors; Vindesine | 2000 |
Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carboplatin; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Proteins; Paclitaxel; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
[A case of large-cell lung cancer responding remarkably to combination chemotherapy with vinorelbine, mitomycin C and carboplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Drug Administration Schedule; Drug Evaluation; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Vinblastine; Vinorelbine | 2000 |
Fas antigen expression and outcome of oral squamous cell carcinoma.
Topics: Actuarial Analysis; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; fas Receptor; Female; Humans; Immunohistochemistry; Logistic Models; Male; Middle Aged; Mitomycin; Mouth Neoplasms; Peplomycin; Proliferating Cell Nuclear Antigen; Treatment Outcome | 2000 |
[A case of multiple liver metastasis of gastric cancer which was effectively treated by arterial infusion chemotherapy with hyperthermia and 10 years survival].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Embolization, Therapeutic; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survivors | 2001 |
Characterization of the mutational specificity of DNA cross-linking mutagens by the Lac+ reversion assay with Escherichia coli.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Cross-Linking Reagents; Dose-Response Relationship, Drug; Escherichia coli; Ficusin; Lac Operon; Light; Methoxsalen; Mitomycin; Mutagenicity Tests; Mutagens; Mutation; Photosensitizing Agents; Point Mutation | 2001 |
Malignant fibrous histiocytoma of the trunk metastatic to the liver: treatment with transcatheter intrahepatic chemoembolization.
Topics: Carboplatin; Chemoembolization, Therapeutic; Epirubicin; Histiocytoma, Benign Fibrous; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Thoracic Neoplasms | 2001 |
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Immunologic Factors; Lung Neoplasms; Mitomycin; Neoplasm Metastasis; Paclitaxel; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Vinblastine; Vinorelbine | 2001 |
Mitomycin C, vinblastine and carboplatin: effective outpatient chemotherapy for advanced non-small cell carcinoma of the lung (NSCLC).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Home Infusion Therapy; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Treatment Outcome; Vinblastine | 2001 |
[Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
[Apoptosis of human pancreatic carcinoma cell lines induced by combinations of chemotherapeutic drugs].
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Doxorubicin; Epirubicin; Fluorouracil; Humans; Mitomycin; Pancreatic Neoplasms; Tumor Cells, Cultured | 1999 |
Treatment of interstitial peumopathy by fei tong oral liquid in the malignant tumor patients after radio- and/or chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drugs, Chinese Herbal; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Phytotherapy; Radiation Pneumonitis; Stomach Neoplasms | 2003 |
In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents.
Topics: Acrylates; Antineoplastic Agents; Biocompatible Materials; Carboplatin; Chemical Phenomena; Chemistry, Physical; Chemoembolization, Therapeutic; Doxorubicin; Drug Carriers; Fluorouracil; Gelatin; In Vitro Techniques; Methylamines; Microspheres; Mitomycin | 2003 |
[The role of surgical therapy for esophageal microcytoma. Experience of there clinical cases and results analysis].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Esophagoplasty; Esophagoscopy; Etoposide; Fatal Outcome; Female; Humans; Laparotomy; Lymph Node Excision; Male; Middle Aged; Mitomycin; Remission Induction; Stomach; Thoracotomy; Vinblastine; Vinorelbine | 2003 |
A young woman with clear cell adenocarcinoma of the uterine cervix.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinogens; Diethylstilbestrol; Etoposide; Female; Humans; Hysterectomy; Japan; Lymph Node Excision; Mitomycin; Neoadjuvant Therapy; Netherlands; Prognosis; Uterine Cervical Neoplasms | 2003 |
[The Czech experience in peritonectomy and hyperthermic perioperative cytostatic lavage in the treatment of peritoneal malignancy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Czech Republic; Equipment Design; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Peritoneal Lavage; Peritoneal Neoplasms; Peritoneum; Survival Rate | 2004 |
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Prognosis; Survival Analysis; Survival Rate | 2004 |
[Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome | 2004 |
Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Radiotherapy; Radiotherapy Dosage; Survival Analysis; Time Factors; Uterine Cervical Neoplasms | 2005 |
Is the tolerance to MIP chemotherapy different between English and other European populations?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Decision Making; Deoxycytidine; England; Europe; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Randomized Controlled Trials as Topic; Reproducibility of Results | 2005 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Time Factors | 2006 |
HIV-associated anal squamous cell cancer: an otherwise preventable disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Colostomy; Fatal Outcome; Fluorouracil; HIV Infections; Homosexuality, Male; Humans; Laparotomy; Male; Middle Aged; Mitomycin; Paclitaxel; Palliative Care; Radiotherapy, Adjuvant | 2006 |
The apoptotic effect of intercalating agents on HPV-negative cervical cancer C-33A cells.
Topics: Apoptosis; Blotting, Western; Carboplatin; Caspases; Cell Proliferation; Cisplatin; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Female; Humans; Intercalating Agents; Interleukin-18; Mitomycin; Papillomaviridae; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2007 |
[Drug sensitivity test and drug-resistance gene assessment for chemotherapy planning for tumors derived from high-passage mouse gastric cancer cells: therapeutic effect observation in mice].
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Immunohistochemistry; Mice; Mitomycin; Neoplasm Transplantation; Stomach Neoplasms; Treatment Outcome; Tumor Burden | 2007 |
[Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Gefitinib; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mitomycin; Neoplasm Staging; Paclitaxel; Pneumonectomy; Quinazolines; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate | 2007 |
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma; Cisplatin; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Vincristine | 2008 |
[Chemotherapy of advanced non small cell lung cancer: effect on survival and symptoms affecting quality of life].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Poland; Quality of Life; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine | 2007 |
Resistance to therapy caused by intragenic deletion in BRCA2.
Topics: Aged; Alleles; Amino Acid Sequence; Base Sequence; BRCA2 Protein; Carboplatin; Cell Line, Tumor; Chromosome Aberrations; Drug Resistance, Neoplasm; Female; Fluorobenzenes; Gene Expression Regulation, Neoplastic; Genes, BRCA2; Humans; Middle Aged; Mitomycin; Molecular Sequence Data; Mutation; Open Reading Frames; Ovarian Neoplasms; Pancreatic Neoplasms; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Recombination, Genetic; Sequence Deletion | 2008 |
Platinum-based chemotherapy in triple-negative breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Vinblastine | 2008 |
Treatment options in metastatic squamous cell carcinoma of the anal canal.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Humans; Incidence; Male; Mitomycin; Radiotherapy; Sexually Transmitted Diseases; United States | 2008 |
Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience.
Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Preoperative Care; Radiotherapy, Adjuvant; Vinblastine | 2010 |
Intra-arterial infusion of chemotherapy in the treatment of penile cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Mitomycin; Penile Neoplasms; Remission Induction | 2009 |
Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Databases, Factual; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Mitomycin; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Peritoneum | 2011 |
Chemotherapy-induced toxicity is highly heritable in Drosophila melanogaster.
Topics: Animals; Carboplatin; Deoxycytidine; Dose-Response Relationship, Drug; Drosophila melanogaster; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Fertility; Floxuridine; Gemcitabine; High-Throughput Screening Assays; Humans; Methotrexate; Mitomycin; Models, Animal; Neoplasms; Topotecan | 2012 |
Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Liver Neoplasms; MicroRNAs; Mitomycin; Oligonucleotide Array Sequence Analysis; Up-Regulation; Vincristine | 2013 |
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Neoplasm Staging; Obesity; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prospective Studies; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Databases, Factual; Digestive System Surgical Procedures; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Kaplan-Meier Estimate; Length of Stay; Male; Melphalan; Middle Aged; Mitomycin; Peritoneal Neoplasms; Reoperation; Retrospective Studies; Treatment Outcome | 2013 |
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Ifosfamide; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids | 2013 |
[Morphology and microRNA expression profiles of drug-resistant cells in hepatocellular carcinoma].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Liver Neoplasms; MicroRNAs; Mitomycin; Oligonucleotide Array Sequence Analysis | 2013 |
Combination chemotherapy for metastatic extramammary Paget disease.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Epirubicin; Female; Fluorouracil; Genital Neoplasms, Male; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paget Disease, Extramammary; Retrospective Studies; Treatment Outcome; Vincristine; Vulvar Neoplasms | 2014 |
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Multivariate Analysis; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Peritoneum; Survival Analysis; Thiosulfates; Treatment Outcome; Young Adult | 2014 |
Characterization of LGALS3 (galectin-3) as a player in DNA damage response.
Topics: Antineoplastic Agents; Blood Proteins; BRCA1 Protein; Carboplatin; DNA Damage; DNA Repair; Etoposide; G2 Phase Cell Cycle Checkpoints; Galectin 3; Galectins; Gene Silencing; HEK293 Cells; HeLa Cells; Humans; Mitomycin; Protein Interaction Maps; Signal Transduction; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitination | 2014 |
Comparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesothelioma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Length of Stay; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Mitomycin; Peritoneal Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome | 2014 |
Intraarterial chemotherapy as the first-line therapy in penile cancer.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Fluorouracil; Humans; Infusions, Intra-Arterial; Inguinal Canal; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Penile Neoplasms; Retrospective Studies | 2014 |
Using Drosophila melanogaster to identify chemotherapy toxicity genes.
Topics: Animals; Antineoplastic Agents; Carboplatin; Deoxycytidine; DNA Transposable Elements; Drosophila melanogaster; Drosophila Proteins; Fertility; Gemcitabine; Mitomycin; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Repressor Proteins; Ribonucleoside Diphosphate Reductase; Trans-Activators | 2014 |
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Paclitaxel; Perioperative Care; Retrospective Studies; Urethra; Urethral Neoplasms; Urinary Diversion | 2015 |
Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Patient Selection; Radiotherapy Dosage; Vinblastine; Vinorelbine | 2016 |
Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carboplatin; Chemoembolization, Therapeutic; Cholangiocarcinoma; Cisplatin; Cohort Studies; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Middle Aged; Mitomycin; Starch | 2017 |
[Regional chemotherapy in treatment of patients with unresectable liver metastases of uveal melanoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoembolization, Therapeutic; Disease-Free Survival; Doxorubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Mitomycin; Neoplasm Metastasis; Survival Rate; Uveal Neoplasms | 2016 |
Advanced extramammary Paget disease treated with neoadjuvant chemotherapy: A report of two cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Epirubicin; Fluorouracil; Groin; Humans; Lymph Node Excision; Male; Mitomycin; Neoadjuvant Therapy; Paget Disease, Extramammary; Skin Neoplasms; Vincristine | 2020 |
Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation.
Topics: ATPases Associated with Diverse Cellular Activities; BRCA1 Protein; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Mitomycin; Radiation Tolerance; RNA, Small Interfering; Triple Negative Breast Neoplasms; Up-Regulation | 2020 |
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cytoreduction Surgical Procedures; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Hyperthermic Intraperitoneal Chemotherapy; Laparoscopy; Length of Stay; Male; Mesothelioma; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm, Residual; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Registries; Severity of Illness Index; Survival Rate; Tumor Burden | 2021 |